ALDX Faces Securities Class Action Investigation Amid FDA Setback—What Should Investors Watch Now?
Market Chameleon (Mon, 23-Mar 11:44 AM)
ALDX Faces Class Action After 70% Stock Decline Follows FDA Setback on Lead Drug
Market Chameleon (Thu, 19-Mar 10:35 AM)
Aldeyra Faces FDA Setback, but Cash Position Remains Strong—What’s Next for Reproxalap?
Market Chameleon (Wed, 18-Mar 10:31 AM)
